Winner of the Marie Curie Award of the European Association of Nuclear Medicine (EANM). Best scientific work presented at annual EANM meeting 2023 Vienna, Austria



Molecular imaging predicts response absence to T-DM1 in advanced HER2-positive breast cancer: final results for a prospective phase II ZEPHIR trial. Mileva M et al. (EJNMMI 2023; 50: S261-262): as co-author.
Degree of recognitionInternational